Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Andras Kedves, Akos Gulyban, Csaba Glavak, Gabor Toller, Zoltán Völgyi, Amer Faour, András Bálint, Bernadett Petrási, Tibor Rák & Ferenc Lakosi. (2022) Retrospective validation of coverage probability based simultaneous integrated nodal boost in locally advanced cervical cancer: a mono-institutional analysis. Acta Oncologica 61:2, pages 202-205.
Read now
Read now
Christine Gennigens, Marjolein De Cuypere, Johanne Hermesse, Frédéric Kridelka & Guy Jerusalem. (2021) Optimal treatment in locally advanced cervical cancer. Expert Review of Anticancer Therapy 21:6, pages 657-671.
Read now
Read now
Thomas Berger, Jørgen Breede Baltzer Petersen, Jacob Christian Lindegaard, Lars Ulrik Fokdal & Kari Tanderup. (2017) Impact of bowel gas and body outline variations on total accumulated dose with intensity-modulated proton therapy in locally advanced cervical cancer patients. Acta Oncologica 56:11, pages 1472-1478.
Read now
Read now
Cai Grau, Morten Høyer, Per Rugaard Poulsen, Ludvig Paul Muren, Stine Sofia Korreman, Kari Tanderup, Jacob Christian Lindegaard, Jan Alsner & Jens Overgaard. (2017) Rethink radiotherapy – BIGART 2017. Acta Oncologica 56:11, pages 1341-1352.
Read now
Read now
Jacob Chr. Lindegaard, Marianne Assenholt, Anne Ramlov, Lars Ulrik Fokdal, Markus Alber & Kari Tanderup. (2017) Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer. Acta Oncologica 56:11, pages 1479-1486.
Read now
Read now
Articles from other publishers (36)
Stefano Raffa, Francesco Lanfranchi, Camilla Satragno, Flavio Giannelli, Michela Marcenaro, Angela Coco, Sofia Elizabeth Cena, Luca Sofia, Cecilia Marini, Serafina Mammoliti, Alessia Levaggi, Alberto Stefano Tagliafico, Gianmario Sambuceti, Salvina Barra, Silvia Morbelli, Liliana Belgioia & Matteo Bauckneht. (2023) The prognostic value of FIGO staging defined by combining MRI and [18F]FDG PET/CT in patients with locally advanced cervical cancer. Current Problems in Cancer 47:6, pages 101007.
Crossref
Crossref
Johannes H.A.M. Kaanders, Johan Bussink, Erik H.J.G. Aarntzen, Pètra Braam, Heidi Rütten, Richard W.M. van der Maazen, Marcel Verheij & Sven van den Bosch. (2023) [18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription. Seminars in Radiation Oncology 33:3, pages 287-297.
Crossref
Crossref
Cyrus Chargari, Kari Tanderup, François Planchamp, Luis Chiva, Pauline Humphrey, Alina Sturdza, Li T Tan, Elzbieta van der Steen-Banasik, Ignacio Zapardiel, Remi A Nout & Christina Fotopoulou. (2023) ESGO/ESTRO quality indicators for radiation therapy of cervical cancer. International Journal of Gynecologic Cancer 33:6, pages 862-875.
Crossref
Crossref
Cyrus Chargari, Kari Tanderup, François Planchamp, Luis Chiva, Pauline Humphrey, Alina Sturdza, Li T Tan, Elzbieta van der Steen-Banasik, Ignacio Zapardiel, Remi A Nout & Christina Fotopoulou. (2023) ESGO/ESTRO quality indicators for radiation therapy of cervical cancer. Radiotherapy and Oncology 183, pages 109589.
Crossref
Crossref
Jie Chen, Chen Li, Yuanjie Cao, Li Zhu, Bailin Zhang, Jinqiang You, Hailing Hou, Jing Wang & Zhiyong Yuan. (2022) Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial. BMC Cancer 22:1.
Crossref
Crossref
Sophia Scharl, Clara-Bianca Weidenbaecher, Christine Hugo, Christine E. Brambs, Karina Knorr, Stephanie E. Combs & Lars Schüttrumpf. (2022) First experiences with PET-MRI/CT in radiotherapy planning for cervical cancer. Archives of Gynecology and Obstetrics 306:5, pages 1821-1828.
Crossref
Crossref
Won Hee Lee, Gwi Eon Kim & Yong Bae Kim. (2022) Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy. Journal of Gynecologic Oncology 33:5.
Crossref
Crossref
Iresha Jayatilakebanda, Yat Man Tsang & Peter Hoskin. (2021) High dose simultaneous integrated boost for node positive cervical cancer. Radiation Oncology 16:1.
Crossref
Crossref
Ajay Sasidharan, Umesh Mahantshetty, Supriya Chopra, Lavanya Gurram, Nilendu Purandare, Venkatesh Rangarajan & Shyam Kishore Shrivastava. (2021) Paraaortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18–Fluorodeoxyglucose PET (Positron Emission Tomography) in Advanced Cervical Cancer: Final Results of a Prospective Observational Cohort Study. Indian Journal of Gynecologic Oncology 19:4.
Crossref
Crossref
Anouk Corbeau, Remi A. Nout, Jan Willem M. Mens, Nanda Horeweg, Jérémy Godart, Ellen M. Kerkhof, Sander C. Kuipers, Mariette I. E. van Poelgeest, Judith R. Kroep, Ingrid A. Boere, Helena C. van Doorn, Mischa S. Hoogeman, Uulke A. van der Heide, Hein Putter, Marij J. P. Welters, Sjoerd H. van der Burg, Carien L. Creutzberg & Stephanie M. de Boer. (2021) PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System. Cancers 13:20, pages 5179.
Crossref
Crossref
Max Peters, Astrid A.C. de Leeuw, Christel N. Nomden, Kari Tanderup, Kathrin Kirchheiner, Jacob C. Lindegaard, Christian Kirisits, Christine Haie-Meder, Alina Sturdza, Lars Fokdal, Umesh Mahantshetty, Peter Hoskin, Barbara Segedin, Kjersti Bruheim, Bhavana Rai, Fleur Huang, Rachel Cooper, Elzbieta van der Steen-Banasik, Erik van Limbergen, Bradley R. Pieters, Li Tee Tan, Peter S.N. van Rossum, Nicole Nesvacil, Remi Nout, Maximilian P. Schmid, Richard Pötter & Ina M. Jürgenliemk-Schulz. (2021) Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis. Radiotherapy and Oncology 163, pages 150-158.
Crossref
Crossref
Garrett Lee Jensen, Megan Ann Mezera, Salman Hasan, Kendall Pye Hammonds, Gregory Peter Swanson & Moataz Nier El-Ghamry. (2021) Dose escalated simultaneous integrated boost of gross nodal disease in gynecologic cancers: a multi-institutional retrospective analysis and review of the literature. Radiation Oncology Journal 39:3, pages 219-230.
Crossref
Crossref
Chi Qi, Shasha He, Liang Cai, Li Zhang, Haoyuan Ding & Yue Chen. (2021)
A study on the clinical value of
18
F‑fluorodeoxyglucose positron emission tomography/computed tomography combined with serum squamous cell carcinoma antigen in diagnosing recurrence/metastases in patients with early metaphase cervical cancer
. Oncology Letters 22:5.
Crossref
Crossref
Judit A. Adam, Annika Loft, Cyrus Chargari, Roberto C. Delgado Bolton, Elisabeth Kidd, Heiko Schöder, Patrick Veit-Haibach & Wouter V. Vogel. (2020) EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0. European Journal of Nuclear Medicine and Molecular Imaging 48:4, pages 1188-1199.
Crossref
Crossref
Dennis Winkel, Anita M. Werensteijn-Honingh, Wietse S.C. Eppinga, Martijn P.W. Intven, Jochem Hes, Louk M.W. Snoeren, Sanne A. Visser, Gijsbert H. Bol, Bas W. Raaymakers, Ina M. Jürgenliemk-Schulz & Petra S. Kroon. (2021) Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac. Radiotherapy and Oncology 154, pages 243-248.
Crossref
Crossref
Judit A. Adam, Pascal R. van Diepen, Constantijne H. Mom, Jaap Stoker, Berthe L.F. van Eck-Smit & Shandra Bipat. (2020) [18F]FDG-PET or PET/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: A systematic review of the literature. Gynecologic Oncology 159:2, pages 588-596.
Crossref
Crossref
Gun Oh Chong, Shin Young Jeong, Yoon Hee Lee, Shin-Hyung Park, Hyun Jung Lee, Sang-Woo Lee, Dae Gy Hong & Yoon Soon Lee. (2020) Improving the Prognostic Performance of SUVmax in 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Using Tumor-to-Liver and Tumor-to-Blood Standard Uptake Ratio for Locally Advanced Cervical Cancer Treated with Concurrent Chemoradiotherapy. Journal of Clinical Medicine 9:6, pages 1878.
Crossref
Crossref
Haeyoung Kim, Won Park & Won Kyung Cho. (2020) Who can benefit from a lymph node boost in definitive chemoradiotherapy for node-positive cervical cancer: an evaluation of nodal failure in patients without nodal boost. Journal of Radiation Research 61:3, pages 479-486.
Crossref
Crossref
Kyra N. McComas, Anna M. Torgeson, Bryan J. Ager, Christopher Hellekson, Lindsay M. Burt, Kathryn A. Maurer, Teresa L. Werner & David K. Gaffney. (2020) The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecologic Oncology 156:1, pages 85-92.
Crossref
Crossref
Nemi Gandy, Mubarik A. Arshad, Won-Ho E. Park, Andrea G. Rockall & Tara D. Barwick. (2019) FDG-PET Imaging in Cervical Cancer. Seminars in Nuclear Medicine 49:6, pages 461-470.
Crossref
Crossref
T. Kumar, S. Achkar, C. Haie-Meder & C. Chargari. (2019) Curiethérapie guidée par imagerie multimodale : l’exemple du cancer du col utérin. Cancer/Radiothérapie 23:6-7, pages 765-772.
Crossref
Crossref
Christel N. Nomden, Richard Pötter, Astrid A.C. de Leeuw, Kari Tanderup, Jacob C. Lindegaard, Maximilian P. Schmid, Israël Fortin, Christine Haie-Meder, Umesh Mahantshetty, Peter Hoskin, Barbara Segedin, Kjersti Bruheim, Bhavana Rai, Fleur Huang, Rachel Cooper, Elzbieta Van Der Steen Banasik, Erik Van Limbergen & Ina M. Jürgenliemk-Schulz. (2019) Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort. Radiotherapy and Oncology 134, pages 185-190.
Crossref
Crossref
Ina-Maria Jürgenliemk-Schulz, Sushil Beriwal, Astrid A.C. de Leeuw, Jacob Christian Lindegaard, Christel Nadine Nomden, Richard Pötter, Kari Tanderup, Akila N. Viswanathan & Beth Erickson. (2019) Management of Nodal Disease in Advanced Cervical Cancer. Seminars in Radiation Oncology 29:2, pages 158-165.
Crossref
Crossref
C. Rousseau & P.Y. Salaün. (2019) Cancers de l’ovaire, du col utérin et de l’endomètre. Médecine Nucléaire 43:1, pages 104-124.
Crossref
Crossref
Oyeon Cho & Mison Chun. (2018) Management for locally advanced cervical cancer: new trends and controversial issues. Radiation Oncology Journal 36:4, pages 254-264.
Crossref
Crossref
Shengjun Ji, Qunchao Hu, Jiahao Zhu, Jie Chen, Qingqing Chen, Zhengcao Liu, Chen Shen, Ru Yang, Haoyao Sun, Jinchang Wu & Ke Gu. (2018) Combined pretreatment with 18F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial. Trials 19:1.
Crossref
Crossref
D P Schaap, A Ogura, J Nederend, M Maas, J S Cnossen, G J Creemers, I van Lijnschoten, G A P Nieuwenhuijzen, H J T Rutten & M Kusters. (2018) Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer. British Journal of Surgery 105:13, pages 1844-1852.
Crossref
Crossref
Matthew M. Harkenrider, Basel Altoos & William SmallJr.Jr.. (2018) Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer. Gynecologic Oncology 148:3, pages 437-438.
Crossref
Crossref
Warren Bacorro, Isabelle Dumas, Alexandre Escande, Sebastien Gouy, Enrica Bentivegna, Philippe Morice, Christine Haie-Meder & Cyrus Chargari. (2018) Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer. Gynecologic Oncology 148:3, pages 461-467.
Crossref
Crossref
Richard Pötter, Kari Tanderup, Christian Kirisits, Astrid de Leeuw, Kathrin Kirchheiner, Remi Nout, Li Tee Tan, Christine Haie-Meder, Umesh Mahantshetty, Barbara Segedin, Peter Hoskin, Kjersti Bruheim, Bhavana Rai, Fleur Huang, Erik Van Limbergen, Max Schmid, Nicole Nesvacil, Alina Sturdza, Lars Fokdal, Nina Boje Kibsgaard Jensen, Dietmar Georg, Marianne Assenholt, Yvette Seppenwoolde, Christel Nomden, Israel Fortin, Supriya Chopra, Uulke van der Heide, Tamara Rumpold, Jacob Christian Lindegaard & Ina Jürgenliemk-Schulz. (2018) The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clinical and Translational Radiation Oncology 9, pages 48-60.
Crossref
Crossref
John Weaver, Grant Harmon, Matthew M. Harkenrider, Murat Surucu, Abbie Wood, Fiori Alite & William SmallJr.Jr.. (2018) Delineating the relationship between Point A prescription dose and pelvic lymph node doses in intracavitary high-dose-rate brachytherapy treatment of cervical cancer for use in low- and middle-income countries. Brachytherapy 17:1, pages 201-207.
Crossref
Crossref
Jie Lee, Jhen-Bin Lin, Chih-Long Chang, Ya-Ting Jan, Fang-Ju Sun, Meng-Hao Wu & Yu-Jen Chen. (2017) Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience. Gynecologic Oncology 146:1, pages 20-26.
Crossref
Crossref
Peter de Boer, Ina M. Jürgenliemk-Schulz, Henrike Westerveld, Astrid A.C. de Leeuw, Raquel Dávila-Fajardo, Coen R.N. Rasch, Bradley R. Pieters & Lukas J.A. Stalpers. (2017) Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer. Radiotherapy and Oncology 123:2, pages 306-311.
Crossref
Crossref
Anne Ramlov, Marianne S. Assenholt, Maria F. Jensen, Caroline Grønborg, Remi Nout, Markus Alber, Lars Fokdal, Kari Tanderup & Jacob Chr. Lindegaard. (2017) Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer. Radiotherapy and Oncology 123:1, pages 158-163.
Crossref
Crossref
Joanne Jang, Patrizia Guerrieri & Akila N. Viswanathan. 2018. Alternate Fractionation in Radiotherapy. Alternate Fractionation in Radiotherapy
257
272
.
Shane Mesko & Mitchell Kamrava. (2016) Moving from standardized to personalized boxes and pears in radiation planning for cervical cancer. Current Opinion in Obstetrics & Gynecology 28:1, pages 18-23.
Crossref
Crossref